Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Probe Gold Reports Infill Drilling Results with Grades Up to 3.8 g/t Au Over 17.4 Metres (Cut) at the Novador Project, Quebec
-
Hyperscale Data Announces 31 Consecutive Monthly Cash Dividend Payments Timely Paid for Series D Cumulative Redeemable Perpetual Preferred Stock
-
Sotherly Hotels Inc. Announces Quarterly Preferred Dividends
-
Symbotic Completes Acquisition of Walmart’s Advanced Systems and Robotics Business and Signs Related Commercial Agreement
-
FTAI Aviation Ltd. Announces Timing of Fourth Quarter and Full Year 2024 Earnings and Conference Call
-
Publication of eQ Plc’s 2024 financial statements release and invitation to result presentation
-
Freya Pharma Solutions Strengthens Leadership with Appointment of Distinguished Supervisory Board
-
Form 8.3 - [LOUNGERS PLC - 27 01 2025] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 27 01 2025] - (CGWL)
-
Education to Heal Ukrainian Children’s Invisible War Scars
-
LQUID Finance Announces Launch of LQUID PAY: Bridging Traditional and Decentralized Finance
-
IT Under Siege: AI, Shadow IT, and Security Threats
-
Provident Financial Holdings Reports Second Quarter of Fiscal Year 2025 Results
-
More Than Skin Deep: Canadian Dermatology Association’s Roadmap to Tackle Canada’s Dermatological Wait Times To Improve Health Outcomes
-
Helicore Biopharma Emerges from Stealth to Continue Advancing Portfolio of First-in-Class GIP Antagonists for Obesity and Related Conditions
-
Housing Affordability Requires Modernization of Ontario’s Development Charge System, BILD and OHBA Study
-
RecycLiCo Battery Materials Engages Carmot Strategic Group and Penney Capital for Grants and Cooperative Funding Consultation
-
Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader
-
Sono Group N.V.’s CEO Shareholder Update
-
Form 8.3 - AXA INVESTMENT MANAGERS: Aviva plc
-
Claritas CystoSmart™ Receives Clearance from Brazilian Regulator ANVISA to Market the AI Software Tool for Detection of Bladder Cancer
-
MEXC Leads Q4 2024 Meme Trading Wave: 140% QoQ Volume Growth & 240 New Projects Added
-
MEXC Leads Q4 2024 Meme Trading Wave: 140% QoQ Volume Growth & 240 New Projects Added
-
Net Asset Value(s)
-
MEXC Launches Venice Token (VVV) in Innovation Zone and Futures Trading with Leverage Up to 50x
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - HARGREAVES LANSDOWN PLC - Ordinary Shares
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Team Internet Group plc
-
Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence
-
Dimensional Fund Advisors Ltd. : Form 8.3 - AVIVA PLC - Ordinary Shares
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Loungers plc
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Elanders AB: Year-end Report 2024
-
ITM Announces Positive Topline Results of Phase 3 COMPETE Trial with ITM-11, a Targeted Radiopharmaceutical Therapy, in Patients with Grade 1 or Grade 2 Gastroenteropancreatic Neuroendocrine Tumors (G
-
Form 8.5 (EPT/RI) - Brown (N.) Group plc
-
Form 8.5 (EPT/RI) - Poolbeg Pharma Plc
-
Form 8.5 (EPT/RI) - Warpaint London Plc
-
Auction of Treasury Bills on 30 January 2025
-
Curium Further Expands European Availability of PYLCLARI – an Innovative 18F-PSMA PET Radiopharmaceutical Indicated in Patients with Prostate Cancer
-
Cornish Metals Inc: Strategic Investment and Proposed Fundraising of a minimum of £56 million
-
RESULT OF RIKSBANK CERTIFICATE SALE
-
Arbitration decision in favour of IDEX Biometrics
-
Disclosure of total number of voting rights and number of shares in the capital at December 31, 2024
-
Consumers Expectation Gap is Widening: 82% of Consumers Express Concerns About Entering Personal Details Online
-
Proposals to Annual General Meeting 2025 concerning the Number of the Board Members, Their Remuneration and Reimbursement of Their Costs, and Nomination of the Board Members
-
ENA Respiratory Publishes Review of Development of Novel Intranasal Antiviral Host Defense Immune Enhancer INNA-051 in Antiviral Research
-
Lupin and Avas Launch NaMuscla® in Italy
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Form 8.5 (EPT/RI) - Alliance Pharma plc
-
Form 8.5 (EPT/RI) - De La Rue plc

